1Behegue I, Poirier O, Nicaud V, et al. Fibrinogen gene polymorphismsare associated with plasma fibrinogen and coronary heart disease in patients with myocardial infarction, The ECTIM study [J]. Circulation,1996,93(3) :440-449.
2Junker R, Heinrich J, Schulte H, et al. Coaculation factor Ⅶ and therisk of coronary heart disease in healthy men[Jl. Arterioscler Thromb Vase Biol. 1997o 17(8) : 1539-1544.
3Rifai N, Tracy RB, Ridker PM. Clinical efficacy of an automated highsensitivity C-reactive protein assay [ J ]. Clin Chem, 1999, 45 (12) :2136-2141.
4Retterstol L, Eikvar L, Bohn M, et al. Atherosclero6is. C-reactive protein predicts death in patients with previous premature myocardial infarctiot-a 10 year follow-up study [ J ]. Atherusclerosis, 2002, 160(2) :433-440.
5St-Pierre AC, Bergeron J, Pirro M, et al. Effect of plasma C-reactive protein levels in modulating the risk of coronary heart disease associated with small, dense, low-density lipoproteins in men (The Quebec Cardiovascular Study)[J] .Am J Carcliol,2003,91 (5) :555-558.
6Krausse R, Leiendecker J, Hemnann G, et al. Chlamydia pneumoniaeinfection and restenosis in patients with coronary heart diseaseEJ] . In-fection,2003,31 (3) : 149-154.
7Roivainen M, Alfthan G, Jousilahti P, et al. Enterovirus infections as a possible risk factor for myocardial infarction E J ]. Circulation, 1998,98(23) :2534-2537.
8Roivainen M, Viik-Kajander M, Palosuo T, et a2. Infections, inflammation and the risk coronary heart disease[J]. Circulation, 2000,101 (3) :252-2.57.
10Ehara S, Ueda M, Naruko T, et al. Elevated levels of oxidized low-density lipoprotein show a positive relationship with the severity of acutecoronary syndromes[J]. Circulation,2001,103(15) : 1955-1960.
